Circulating Tumor Cell Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the global circulating tumor cell market looks promising with opportunities in the hospital, clinics, research and academic institutes, and diagnostic centers. The global circulating tumor cell market is expected to grow with a CAGR of 12%-14% from 2020 to 2025. The major drivers for this market are increasing prevalence of cancer, rising genetic disorder diseases, and increasing consumption of alcohol and smoking.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global circulating tumor cell market report, please download the report brochure.
The study includes trends and forecast for the global circulating tumor cell market by product, specimen, technology, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
Lucintel forecasts that the devices or systems will remain the largest segment over the forecast period due to presence of a wide portfolio of devices or systems and new technological advances in microfluidics technology.
Within this market, hospital and clinics will remain the fastest growing segment by end user over the forecast period as CTC (Circulating Tumor Cell) tests are mostly performed in hospitals and increasing adoption of hospitals over other medical facilities by people in developing economies.
North America will remain the largest region and it is also expected to witness the highest growth over the forecast period due to increasing prevelance of cancer and technical advancements in cancer care infrastructure in the region.
Features of the Global Circulating Tumor Cell Market
Q.1 What are some of the most promising potential, high-growth opportunities for the global circulating tumor cell market by product (kits & reagents, blood collection tubes, and devices or systems), specimen (blood, bone marrow and other body fluids), technology (CTC detection & enrichment methods, CTC direct detection methods, and CTC analysis), application (clinical/ liquid biopsy (risk assessment and screening & monitoring) and research (cancer stem cell & tumorigenesis research and drug/therapy development)), end user (hospital & clinics, research & academic institutes, and diagnostic centers), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global circulating tumor cell market?
Q.5 What are the business risks and threats to the global circulating tumor cell market?
Q.6 What are the emerging trends in this circulating tumor cell market and the reasons behind them?
Q.7 What are some changing demands of customers in this circulating tumor cell market?
Q.8 What are the new developments in this circulating tumor cell market? Which companies are leading these developments?
Q.9 Who are the major players in this circulating tumor cell market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this circulating tumor cell market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global circulating tumor cell market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Kits & Reagents, Blood Collection Tubes, and Devices Or Systems), Specimen (Blood, Bone Marrow and Other Body Fluids), Technology (CTC Detection & Enrichment Methods, CTC Direct Detection Methods, and CTC Analysis), Application (Clinical/ Liquid Biopsy (Risk Assessment and Screening & Monitoring) and Research (Cancer Stem Cell & Tumorigenesis Research and Drug/Therapy Development)), and End User (Hospital & Clinics, Research & Academic Institutes, and Diagnostic Centers)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the global circulating tumor cell market looks promising with opportunities in the hospital, clinics, research and academic institutes, and diagnostic centers. The global circulating tumor cell market is expected to grow with a CAGR of 12%-14% from 2020 to 2025. The major drivers for this market are increasing prevalence of cancer, rising genetic disorder diseases, and increasing consumption of alcohol and smoking.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global circulating tumor cell market report, please download the report brochure.
The study includes trends and forecast for the global circulating tumor cell market by product, specimen, technology, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
- Kits & Reagents
- Blood Collection Tubes
- Devices or Systems
- Blood
- Bone Marrow
- Other Body Fluids
- CTC Detection & Enrichment Methods
- CTC Direct Detection Methods
- CTC Analysis
- Clinical/ Liquid Biopsy
- Risk Assessment
- Screening and Monitoring
- Research
- Cancer Stem Cell & Tumorigenesis Research
- Drug/Therapy Development
- Hospital & Clinics
- Research & Academic Institutes
- Diagnostic Centers
- North America
- United States
- Canada
- Mexico
- Europe
- United Kingdom
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- The Rest of the World
- Brazil
Lucintel forecasts that the devices or systems will remain the largest segment over the forecast period due to presence of a wide portfolio of devices or systems and new technological advances in microfluidics technology.
Within this market, hospital and clinics will remain the fastest growing segment by end user over the forecast period as CTC (Circulating Tumor Cell) tests are mostly performed in hospitals and increasing adoption of hospitals over other medical facilities by people in developing economies.
North America will remain the largest region and it is also expected to witness the highest growth over the forecast period due to increasing prevelance of cancer and technical advancements in cancer care infrastructure in the region.
Features of the Global Circulating Tumor Cell Market
- Market Size Estimates: Global circulating tumor cell market size estimation in terms of value ($M) shipment.
- Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.
- Segmentation Analysis: Global circulating tumor cell market size by various segments, such as product, specimen, technology, application, and end user in terms of value.
- Regional Analysis: Global circulating tumor cell market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different product, specimen, technology, application, end user, and region for the global circulating tumor cell market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global circulating tumor cell market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
Q.1 What are some of the most promising potential, high-growth opportunities for the global circulating tumor cell market by product (kits & reagents, blood collection tubes, and devices or systems), specimen (blood, bone marrow and other body fluids), technology (CTC detection & enrichment methods, CTC direct detection methods, and CTC analysis), application (clinical/ liquid biopsy (risk assessment and screening & monitoring) and research (cancer stem cell & tumorigenesis research and drug/therapy development)), end user (hospital & clinics, research & academic institutes, and diagnostic centers), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global circulating tumor cell market?
Q.5 What are the business risks and threats to the global circulating tumor cell market?
Q.6 What are the emerging trends in this circulating tumor cell market and the reasons behind them?
Q.7 What are some changing demands of customers in this circulating tumor cell market?
Q.8 What are the new developments in this circulating tumor cell market? Which companies are leading these developments?
Q.9 Who are the major players in this circulating tumor cell market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this circulating tumor cell market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global circulating tumor cell market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Kits & Reagents, Blood Collection Tubes, and Devices Or Systems), Specimen (Blood, Bone Marrow and Other Body Fluids), Technology (CTC Detection & Enrichment Methods, CTC Direct Detection Methods, and CTC Analysis), Application (Clinical/ Liquid Biopsy (Risk Assessment and Screening & Monitoring) and Research (Cancer Stem Cell & Tumorigenesis Research and Drug/Therapy Development)), and End User (Hospital & Clinics, Research & Academic Institutes, and Diagnostic Centers)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Circulating Tumor Cell Market Trends and Forecast
3.3: Global Circulating Tumor Cell Market by Product
3.3.1: Kits & Reagents
3.3.2: Blood Collection Tubes
3.3.3: Devices or Systems
3.4: Global Circulating Tumor Cell Market by Specimen
3.4.1: Blood
3.4.2: Bone Marrow
3.4.3: Other Body Fluids
3.5: Global Circulating Tumor Cell Market by Technology
3.5.1: CTC Detection & Enrichment Methods
3.5.2: CTC Direct Detection Methods
3.5.3: CTC Analysis
3.6: Global Circulating Tumor Cell Market by Application
3.6.1: Clinical/ Liquid Biopsy
3.6.1.1: Risk Assessment
3.6.1.2: Screening and Monitoring
3.6.2: Research
3.6.2.1: Cancer Stem Cell & Tumorigenesis Research
3.6.2.2: Drug/Therapy Development
3.7: Global Circulating Tumor Cell Market by End User
3.7.1: Hospital & Clinics
3.7.2: Research & Academic Institutes
3.7.3: Diagnostic Centers
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Circulating Tumor Cell Market by Region
4.2: North American Circulating Tumor Cell Market
4.2.1: Market by Product: Kits & Reagents, Blood Collection Tubes, and Devices or Systems
4.2.2: Market by Specimen: Blood, Bone Marrow and Other Body Fluids
4.2.3: Market by Technology: CTC Detection & Enrichment Methods, CTC Direct Detection Methods, and CTC Analysis
4.2.4: Market by Application: Clinical/ Liquid Biopsy (Risk Assessment and Screening and Monitoring) and Research (Cancer Stem Cell & Tumorigenesis Research and Drug/Therapy Development)
4.2.5: Market by End User: Hospital & Clinics, Research & Academic Institutes, and Diagnostic Centers
4.2.6: The United States Circulating Tumor Cell Market
4.2.7: The Canadian Circulating Tumor Cell Market
4.2.8: The Mexican Circulating Tumor Cell Market
4.3: European Circulating Tumor Cell Market
4.3.1: Market by Product: Kits & Reagents, Blood Collection Tubes, and Devices or Systems
4.3.2: Market by Specimen: Blood, Bone Marrow and Other Body Fluids
4.3.3: Market by Technology: CTC Detection & Enrichment Methods, CTC Direct Detection Methods, and CTC Analysis
4.3.4: Market by Application: Clinical/ Liquid Biopsy (Risk Assessment and Screening and Monitoring) and Research (Cancer Stem Cell & Tumorigenesis Research and Drug/Therapy Development)
4.3.5: Market by End User: Hospital & Clinics, Research & Academic Institutes, and Diagnostic Centers
4.3.6: The Circulating Tumor Cell Market of United Kingdom
4.3.7: The German Circulating Tumor Cell Market
4.3.8: The French Circulating Tumor Cell Market
4.4: APAC Circulating Tumor Cell Market
4.4.1: Market by Product: Kits & Reagents, Blood Collection Tubes, and Devices or Systems
4.4.2: Market by Specimen: Blood, Bone Marrow and Other Body Fluids
4.4.3: Market by Technology: CTC Detection & Enrichment Methods, CTC Direct Detection Methods, and CTC Analysis
4.4.4: Market by Application: Clinical/ Liquid Biopsy (Risk Assessment and Screening and Monitoring) and Research (Cancer Stem Cell & Tumorigenesis Research and Drug/Therapy Development)
4.4.5: Market by End User: Hospital & Clinics, Research & Academic Institutes, and Diagnostic Centers
4.4.6: The Chinese Circulating Tumor Cell Market
4.4.7: The Indian Circulating Tumor Cell Market
4.4.8: The Japanese Circulating Tumor Cell Market
4.5: ROW Circulating Tumor Cell Market
4.5.1: Market by Product: Kits & Reagents, Blood Collection Tubes, and Devices or Systems
4.5.2: Market by Specimen: Blood, Bone Marrow and Other Body Fluids
4.5.3: Market by Technology: CTC Detection & Enrichment Methods, CTC Direct Detection Methods, and CTC Analysis
4.5.4: Market by Application: Clinical/ Liquid Biopsy (Risk Assessment and Screening and Monitoring) and Research (Cancer Stem Cell & Tumorigenesis Research and Drug/Therapy Development)
4.5.5: Market by End User: Hospital & Clinics, Research & Academic Institutes, and Diagnostic Centers
4.5.6: Brazilian Circulating Tumor Cell Market
5.COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Circulating Tumor Cell Market by Product
7.1.2: Growth Opportunities for the Global Circulating Tumor Cell Market by Specimen
7.1.3: Growth Opportunities for the Global Circulating Tumor Cell Market by Technology
7.1.4: Growth Opportunities for the Global Circulating Tumor Cell Market by Application
7.1.5: Growth Opportunities for the Global Circulating Tumor Cell Market by End User
7.1.6: Growth Opportunities for the Global Circulating Tumor Cell Market by Region
7.2: Emerging Trends in the Global Circulating Tumor Cell Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Circulating Tumor Cell Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Circulating Tumor Cell Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Advanced Cell Diagnostics
8.2: Apocell, Inc.
8.3: Aviva Biosciences
8.4: Biocept, Inc.
8.5: Biofluidica, Inc.
8.6: CellTraffix
8.7: QIAGEN
8.8: Bio-Techne Corporation
8.9: BioCep Ltd.
8.10: Fluxion Biosciences, Inc.
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Circulating Tumor Cell Market Trends and Forecast
3.3: Global Circulating Tumor Cell Market by Product
3.3.1: Kits & Reagents
3.3.2: Blood Collection Tubes
3.3.3: Devices or Systems
3.4: Global Circulating Tumor Cell Market by Specimen
3.4.1: Blood
3.4.2: Bone Marrow
3.4.3: Other Body Fluids
3.5: Global Circulating Tumor Cell Market by Technology
3.5.1: CTC Detection & Enrichment Methods
3.5.2: CTC Direct Detection Methods
3.5.3: CTC Analysis
3.6: Global Circulating Tumor Cell Market by Application
3.6.1: Clinical/ Liquid Biopsy
3.6.1.1: Risk Assessment
3.6.1.2: Screening and Monitoring
3.6.2: Research
3.6.2.1: Cancer Stem Cell & Tumorigenesis Research
3.6.2.2: Drug/Therapy Development
3.7: Global Circulating Tumor Cell Market by End User
3.7.1: Hospital & Clinics
3.7.2: Research & Academic Institutes
3.7.3: Diagnostic Centers
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Circulating Tumor Cell Market by Region
4.2: North American Circulating Tumor Cell Market
4.2.1: Market by Product: Kits & Reagents, Blood Collection Tubes, and Devices or Systems
4.2.2: Market by Specimen: Blood, Bone Marrow and Other Body Fluids
4.2.3: Market by Technology: CTC Detection & Enrichment Methods, CTC Direct Detection Methods, and CTC Analysis
4.2.4: Market by Application: Clinical/ Liquid Biopsy (Risk Assessment and Screening and Monitoring) and Research (Cancer Stem Cell & Tumorigenesis Research and Drug/Therapy Development)
4.2.5: Market by End User: Hospital & Clinics, Research & Academic Institutes, and Diagnostic Centers
4.2.6: The United States Circulating Tumor Cell Market
4.2.7: The Canadian Circulating Tumor Cell Market
4.2.8: The Mexican Circulating Tumor Cell Market
4.3: European Circulating Tumor Cell Market
4.3.1: Market by Product: Kits & Reagents, Blood Collection Tubes, and Devices or Systems
4.3.2: Market by Specimen: Blood, Bone Marrow and Other Body Fluids
4.3.3: Market by Technology: CTC Detection & Enrichment Methods, CTC Direct Detection Methods, and CTC Analysis
4.3.4: Market by Application: Clinical/ Liquid Biopsy (Risk Assessment and Screening and Monitoring) and Research (Cancer Stem Cell & Tumorigenesis Research and Drug/Therapy Development)
4.3.5: Market by End User: Hospital & Clinics, Research & Academic Institutes, and Diagnostic Centers
4.3.6: The Circulating Tumor Cell Market of United Kingdom
4.3.7: The German Circulating Tumor Cell Market
4.3.8: The French Circulating Tumor Cell Market
4.4: APAC Circulating Tumor Cell Market
4.4.1: Market by Product: Kits & Reagents, Blood Collection Tubes, and Devices or Systems
4.4.2: Market by Specimen: Blood, Bone Marrow and Other Body Fluids
4.4.3: Market by Technology: CTC Detection & Enrichment Methods, CTC Direct Detection Methods, and CTC Analysis
4.4.4: Market by Application: Clinical/ Liquid Biopsy (Risk Assessment and Screening and Monitoring) and Research (Cancer Stem Cell & Tumorigenesis Research and Drug/Therapy Development)
4.4.5: Market by End User: Hospital & Clinics, Research & Academic Institutes, and Diagnostic Centers
4.4.6: The Chinese Circulating Tumor Cell Market
4.4.7: The Indian Circulating Tumor Cell Market
4.4.8: The Japanese Circulating Tumor Cell Market
4.5: ROW Circulating Tumor Cell Market
4.5.1: Market by Product: Kits & Reagents, Blood Collection Tubes, and Devices or Systems
4.5.2: Market by Specimen: Blood, Bone Marrow and Other Body Fluids
4.5.3: Market by Technology: CTC Detection & Enrichment Methods, CTC Direct Detection Methods, and CTC Analysis
4.5.4: Market by Application: Clinical/ Liquid Biopsy (Risk Assessment and Screening and Monitoring) and Research (Cancer Stem Cell & Tumorigenesis Research and Drug/Therapy Development)
4.5.5: Market by End User: Hospital & Clinics, Research & Academic Institutes, and Diagnostic Centers
4.5.6: Brazilian Circulating Tumor Cell Market
5.COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Circulating Tumor Cell Market by Product
7.1.2: Growth Opportunities for the Global Circulating Tumor Cell Market by Specimen
7.1.3: Growth Opportunities for the Global Circulating Tumor Cell Market by Technology
7.1.4: Growth Opportunities for the Global Circulating Tumor Cell Market by Application
7.1.5: Growth Opportunities for the Global Circulating Tumor Cell Market by End User
7.1.6: Growth Opportunities for the Global Circulating Tumor Cell Market by Region
7.2: Emerging Trends in the Global Circulating Tumor Cell Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Circulating Tumor Cell Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Circulating Tumor Cell Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Advanced Cell Diagnostics
8.2: Apocell, Inc.
8.3: Aviva Biosciences
8.4: Biocept, Inc.
8.5: Biofluidica, Inc.
8.6: CellTraffix
8.7: QIAGEN
8.8: Bio-Techne Corporation
8.9: BioCep Ltd.
8.10: Fluxion Biosciences, Inc.
